Literature DB >> 2999549

Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia.

B E Suranyi-Cadotte, S Gauthier, F Lafaille, S DeFlores, T V Dam, N P Nair, R Quirion.   

Abstract

Platelet 3H-imipramine binding and serotonin uptake were studied simultaneously in normal subjects and in depressed, parkinsonian and Alzheimer's disease patients to investigate the usefulness of these variables in the diagnosis of depression in the elderly. Whereas Vmax of platelet serotonin uptake was significantly reduced in all patient groups compared to age matched normal subjects, the density of 3H-imipramine binding was reduced in depressed patients only. The lower Bmax values in depressed patients was independent of patient age. These data suggest that platelet 3H-imipramine binding may be a useful laboratory index which discriminates depression from dementia in the elderly.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999549     DOI: 10.1016/0024-3205(85)90022-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

Review 1.  Membrane transport and disease.

Authors:  C A Pasternak
Journal:  Mol Cell Biochem       Date:  1989 Nov 23-Dec 19       Impact factor: 3.396

Review 2.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 3.  Platelet research in psychiatry.

Authors:  A Wirz-Justice
Journal:  Experientia       Date:  1988-02-15

4.  Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding.

Authors:  M F Poirier; A M Galzin; C Pimoule; H Schoemaker; K H Le Quan Bui; P Meyer; C Gay; H Loo; S Z Langer
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 5.  Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities.

Authors:  Benedetta Izzi; Alfonsina Tirozzi; Chiara Cerletti; Maria Benedetta Donati; Giovanni de Gaetano; Marc F Hoylaerts; Licia Iacoviello; Alessandro Gialluisi
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

6.  Alzheimer disease and platelets: how's that relevant.

Authors:  Silvia Catricala; Mauro Torti; Giovanni Ricevuti
Journal:  Immun Ageing       Date:  2012-09-17       Impact factor: 6.400

Review 7.  Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?

Authors:  Michael Veitinger; Balazs Varga; Sheila B Guterres; Maria Zellner
Journal:  Acta Neuropathol Commun       Date:  2014-06-16       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.